1995
DOI: 10.1007/bf00193702
|View full text |Cite
|
Sign up to set email alerts
|

Debrisoquine hydroxylation in a Polish population

Abstract: The genetic polymorphism of drug oxidation mediated by cytochrome P450IID6 (CYP2D6) was determined in 154 Polish volunteers using debrisoquine as the test substance. The results showed a bimodal distribution of the debrisoquine metabolic ratio (MR). Nine persons (5.8%) with MR > 12.6 were classified as poor metabolisers (gene frequency 0.242), which is in substantial agreement with the data reported for other Caucasian populations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

1997
1997
2002
2002

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 17 publications
1
1
0
Order By: Relevance
“…So far, two tobacco smoke components: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and nicotine, have been proposed as substrates for CYP2D6 (Crespi et al, 1991;Cholerton et al, 1994). The frequency of predicted phenotypes for our group of patients is almost identical to the frequency of phenotypes determined by pharmacogenetic methods in a healthy Polish population (EM: 58% by genotyping vs 57% by metabolite measurements, IM 37% vs 37%, PM 5% vs 6%) (Kunicki et al, 1995). Considering the CYP2D6 genotype (presence of alleles A and B), we classified the patients by the two predicted phenotypes (EM or IM and PM).…”
Section: supporting
confidence: 52%
“…So far, two tobacco smoke components: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and nicotine, have been proposed as substrates for CYP2D6 (Crespi et al, 1991;Cholerton et al, 1994). The frequency of predicted phenotypes for our group of patients is almost identical to the frequency of phenotypes determined by pharmacogenetic methods in a healthy Polish population (EM: 58% by genotyping vs 57% by metabolite measurements, IM 37% vs 37%, PM 5% vs 6%) (Kunicki et al, 1995). Considering the CYP2D6 genotype (presence of alleles A and B), we classified the patients by the two predicted phenotypes (EM or IM and PM).…”
Section: supporting
confidence: 52%
“…Previous Polish population studies have been based on smaller material. Kunicki et al [13] found 5.8% PM of debrisoquine in 156 phenotyped persons, Gawronska-Szklarz et al [14] revealed 9.6% PM in 145 genotyped persons, and our preliminary results showed 8.8% PM in 160 phenotyped persons [15]. The frequency distributions of CYP2D6*1, CYP2D6*3, and CYP2D6*4 alleles (75.7%, 1.3%, and 23.0%, respectively) in our study are similar to those in other white populations.…”
Section: Discussionmentioning
confidence: 98%